Seer (SEER) Proxy filing summary

Executive summary

• Annual Meeting scheduled for July 28, with all shareholders encouraged to vote for the current board nominees on the BLUE proxy card.

• Emphasis on recent progress, scientific breakthroughs, and the shared ownership among employees and stockholders.

• Forward-looking statements highlight confidence in current strategy and leadership, while acknowledging risks and uncertainties.

Voting matters and shareholder proposals

• Two stockholders, Bradley Radoff and Michael Torok, are seeking to replace three board members with their own nominees.

• The board urges shareholders to vote against these nominees, citing lack of relevant experience.

• Voting instructions provided, with emphasis on the importance of every vote.

Board of directors and corporate governance

• Current board described as highly qualified, with experience in proteomics, life sciences tools, and platform operations.

• Board believes continuity is critical to maintaining momentum and achieving future goals.